TY - JOUR
T1 - Epidemiology of asthma and associated factors in an urban Pakistani population
T2 - Adult asthma study-Karachi
AU - Razzaq, Shama
AU - Nafees, Asaad Ahmed
AU - Rabbani, Unaib
AU - Irfan, Muhammad
AU - Naeem, Shahla
AU - Khan, Muhammad Arslan
AU - Fatmi, Zafar
AU - Burney, Peter
N1 - Publisher Copyright:
© 2018 The Author(s).
PY - 2018/12/4
Y1 - 2018/12/4
N2 - Background: This study was conducted in order to determine the prevalence of asthma and associated risk factors in the adult population of Karachi, Pakistan. Methods: This multi-stage, cross-sectional survey was conducted from May 2014-August 2015; comprising 1629 adults in 75 randomly selected clusters in Karachi, Pakistan. Definitions included: 'self-reported asthma', 'reversibility in FEV 1 ' and 'respiratory symptoms and reversibility in FEV 1 '. Results: Prevalence of asthma was 1.8% (self-reported) (95% CI: 1.0-2.6), 11.3% (reversibility in FEV 1 ) (95% CI: 9.4-13.3) and 6.6% (symptoms and reversibility in FEV 1 ) (95% CI: 5.1-8.1). Asthmatics were more likely to belong to the age group ≥38 years according to 'reversibility in FEV 1 ' and 'respiratory symptoms and reversibility in FEV 1 ' (AOR: 1.9, 95% CI: 1.2-3.3) and (AOR: 2.1, 95% CI: 1.1-4.2), respectively. Asthmatics were more likely to report history of allergies (AOR: 1.9, 95% CI: 1.2-2.9) and (AOR: 2.8, 95% CI: 1.7-4.8); and were exposed to environmental tobacco smoke (AOR: 1.6, 95% CI: 1.1-2.5) and (AOR: 1.9, 95% CI: 1.1-3.3) according to 'reversibility in FEV 1 ' and 'respiratory symptoms and reversibility in FEV 1 ', respectively. Asthmatics were more likely to report pack years of smoking ≥5 (AOR: 2.3, 95% CI: 1.1-4.7) according to 'respiratory symptoms and reversibility in FEV 1 '. Conclusion: This study reports a high prevalence of asthma among Pakistani adults and calls for developing appropriate public health policies for prevention and control of asthma in the country. Further studies should be conducted to determine the national prevalence as well as follow-up studies to identify preventable causes for adult asthma.
AB - Background: This study was conducted in order to determine the prevalence of asthma and associated risk factors in the adult population of Karachi, Pakistan. Methods: This multi-stage, cross-sectional survey was conducted from May 2014-August 2015; comprising 1629 adults in 75 randomly selected clusters in Karachi, Pakistan. Definitions included: 'self-reported asthma', 'reversibility in FEV 1 ' and 'respiratory symptoms and reversibility in FEV 1 '. Results: Prevalence of asthma was 1.8% (self-reported) (95% CI: 1.0-2.6), 11.3% (reversibility in FEV 1 ) (95% CI: 9.4-13.3) and 6.6% (symptoms and reversibility in FEV 1 ) (95% CI: 5.1-8.1). Asthmatics were more likely to belong to the age group ≥38 years according to 'reversibility in FEV 1 ' and 'respiratory symptoms and reversibility in FEV 1 ' (AOR: 1.9, 95% CI: 1.2-3.3) and (AOR: 2.1, 95% CI: 1.1-4.2), respectively. Asthmatics were more likely to report history of allergies (AOR: 1.9, 95% CI: 1.2-2.9) and (AOR: 2.8, 95% CI: 1.7-4.8); and were exposed to environmental tobacco smoke (AOR: 1.6, 95% CI: 1.1-2.5) and (AOR: 1.9, 95% CI: 1.1-3.3) according to 'reversibility in FEV 1 ' and 'respiratory symptoms and reversibility in FEV 1 ', respectively. Asthmatics were more likely to report pack years of smoking ≥5 (AOR: 2.3, 95% CI: 1.1-4.7) according to 'respiratory symptoms and reversibility in FEV 1 '. Conclusion: This study reports a high prevalence of asthma among Pakistani adults and calls for developing appropriate public health policies for prevention and control of asthma in the country. Further studies should be conducted to determine the national prevalence as well as follow-up studies to identify preventable causes for adult asthma.
KW - Adult
KW - Asthma
KW - Epidemiology
KW - Pakistan
KW - Risk factors
KW - Spirometry
UR - http://www.scopus.com/inward/record.url?scp=85057603621&partnerID=8YFLogxK
U2 - 10.1186/s12890-018-0753-y
DO - 10.1186/s12890-018-0753-y
M3 - Article
C2 - 30514250
AN - SCOPUS:85057603621
SN - 1471-2466
VL - 18
JO - BMC Pulmonary Medicine
JF - BMC Pulmonary Medicine
IS - 1
M1 - 184
ER -